Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer

NCT03182959 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT03182959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03182959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Study Evaluating the Systemic Bioavailability and Pharmacodynamic Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer
Lead sponsor
University of Arizona
Phase
Phase 1
Overall status
Completed
Start date
April 24, 2017
Completion date
January 19, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma in situ, dysplasia, head and neck cancer, head and neck squamous cell carcinoma, hnscc, hyperplasia, premalignant lesion, tobacco-related carcinoma